Entrar Registro gratuito

IMV Propriedade institucional

Qual é o Propriedade institucional de IMV?

O Propriedade institucional de IMV, Inc. é 20.34%

Qual é a definição de Propriedade institucional?



Propriedade Institucional é a quantidade de ações disponíveis de uma empresa pertencentes a fundos mútuos ou de pensão, seguradoras, empresas de investimento, doações ou outras grandes entidades que administram fundos em nome de terceiros.

Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.

Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.

Propriedade institucional de empresas na Setor Health Care em TSX em comparação com IMV

O que IMV faz?

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Empresas com propriedade institucional semelhantes a IMV